mitoxantrone has been researched along with Hepatitis B Virus Infection in 3 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A total of 20 patients with histologically proven primary hepatocellular carcinoma (PHC) received mitoxantrone IV at a dose of 10-16 mg/m2 every 3 weeks." | 7.67 | Phase II study of mitoxantrone in unresectable primary hepatocellular carcinoma following hepatitis B infection. ( Lai, KH; Lee, SD; Lin, HC; Lin, HJ; Lo, GH; Ng, WW; Tam, TN; Teng, HC; Tsai, YT; Wu, JC, 1989) |
| "Lamivudine was administered for prevention of chemotherapy induced HBV reactivation." | 5.33 | [Development of acute type, CD 8 positive adult T-cell leukemia in a carrier of hepatitis B virus--possible therapeutic effect of lamivudine combined with chemotherapy]. ( Hasegawa, H; Miyagi, T; Nagasaki, A; Nakachi, S; Shinzato, O; Taira, N; Takasu, N; Tomoyose, T, 2006) |
| "A total of 20 patients with histologically proven primary hepatocellular carcinoma (PHC) received mitoxantrone IV at a dose of 10-16 mg/m2 every 3 weeks." | 3.67 | Phase II study of mitoxantrone in unresectable primary hepatocellular carcinoma following hepatitis B infection. ( Lai, KH; Lee, SD; Lin, HC; Lin, HJ; Lo, GH; Ng, WW; Tam, TN; Teng, HC; Tsai, YT; Wu, JC, 1989) |
| "Lamivudine was administered for prevention of chemotherapy induced HBV reactivation." | 1.33 | [Development of acute type, CD 8 positive adult T-cell leukemia in a carrier of hepatitis B virus--possible therapeutic effect of lamivudine combined with chemotherapy]. ( Hasegawa, H; Miyagi, T; Nagasaki, A; Nakachi, S; Shinzato, O; Taira, N; Takasu, N; Tomoyose, T, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, M | 1 |
| Liu, J | 1 |
| Liu, L | 1 |
| Yu, L | 1 |
| Shi, B | 1 |
| Ye, L | 1 |
| Zhang, Y | 1 |
| Chen, H | 1 |
| Nagasaki, A | 1 |
| Taira, N | 1 |
| Tomoyose, T | 1 |
| Miyagi, T | 1 |
| Nakachi, S | 1 |
| Shinzato, O | 1 |
| Hasegawa, H | 1 |
| Takasu, N | 1 |
| Lai, KH | 1 |
| Tsai, YT | 1 |
| Lee, SD | 1 |
| Ng, WW | 1 |
| Teng, HC | 1 |
| Tam, TN | 1 |
| Lo, GH | 1 |
| Lin, HC | 1 |
| Lin, HJ | 1 |
| Wu, JC | 1 |
3 other studies available for mitoxantrone and Hepatitis B Virus Infection
| Article | Year |
|---|---|
A case report of acute myeloid leukemia after liver transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Marrow; Cytarabin | 2013 |
[Development of acute type, CD 8 positive adult T-cell leukemia in a carrier of hepatitis B virus--possible therapeutic effect of lamivudine combined with chemotherapy].
Topics: Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carrier State; CD8-Po | 2006 |
Phase II study of mitoxantrone in unresectable primary hepatocellular carcinoma following hepatitis B infection.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Drug Evaluation; Female; Hepatitis B; Humans; Liver Neoplasm | 1989 |